← Back to All Filings

OHI Grants CAO Equity Award; Potential 4.88% Dilution Impact

High SignificanceJanuary 15, 2026 at 6:31:56 PM EST

OMEGA HEALTHCARE INVESTORS INC

$OHI4CIK: 0000888491

Subscribe to track OHI

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

OHI Grants CAO Equity Award; Potential 4.88% Dilution Impact

Company: OMEGA HEALTHCARE INVESTORS INC (OHI) Form: 4 | Filed: 2026/01/15 Significance: High

Insider: Ballew Neal Title: CHIEF ACCOUNTING OFFICER | Relationship: Officer

Transaction: • Type: Award/Grant • Shares: 14,401 • Price: $0.00 • Value: $0 • Owned After: 124,678

Key Insight: The grant of 14,401 units represents a potential 4.88% dilution to shares outstanding based on provided market data, a highly significant figure.

Market Context: This is a standard equity compensation grant, but its size relative to the provided shares outstanding figure is exceptionally large, warranting shareholder attention regarding dilution.

Comprehensive Analysis

SEC Filing Analysis: OMEGA HEALTHCARE INVESTORS INC (OHI)

Executive Summary

  • Trading Significance: High
  • Key Takeaway: The Chief Accounting Officer received an equity grant of Profits Interest Units which, based on provided market data, represents a potential 4.88% dilution to total shares outstanding.
  • Market Impact: Neutral in the short term as it's a non-cash grant, but the potential dilution is a significant long-term consideration for shareholders.

Company Information

FieldValue
CompanyOMEGA HEALTHCARE INVESTORS INC
Ticker SymbolOHI
CIK0000888491
IndustryREAL ESTATE INVESTMENT TRUSTS [6798]

Insider Information

FieldValue
NameBallew Neal
CIK0001824484
Title/PositionCHIEF ACCOUNTING OFFICER
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2026-01-13
Transaction CodeA
Security TypeProfits Interest Units
Shares Involved14,401
Price Per Share$0.00
Total Value$0
Shares Owned After124,678
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.00%
Shares Transacted14,401
% of Shares Outstanding4.88%
Post-Transaction Ownership124,678 shares (42.26% of outstanding)
Materiality AssessmentHighly Significant

Impact Evaluation

  • Market Cap Context: Omega Healthcare is a large-cap REIT with a $12.99 billion market capitalization. The grant's value is $0, making it immaterial from a value perspective.
  • Ownership Concentration: Post-transaction, the CAO holds derivative securities convertible into 124,678 shares, representing an unusually high 42.26% of the stated shares outstanding. This level of ownership for a non-founding officer is exceptionally high and suggests an anomaly in the provided shares outstanding data.
  • Dilution Impact: The 14,401 units granted represent a potential 4.88% dilution to the 295,000 shares outstanding. This is a very high level of dilution from a single grant to one executive, far exceeding typical compensation practices.
  • Transaction Significance: The significance is rated 'High' not due to the dollar value, but due to the extreme potential dilution (4.88%) relative to the provided shares outstanding figure. This surpasses the 0.5% threshold for high significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: Equity grants are a common form of executive compensation and do not signal an insider's immediate market outlook. The primary impact is potential long-term dilution upon vesting and conversion.

Volume & Sentiment

  • Expected Volume Impact: None. This is not an open market trade and does not directly impact trading volume.
  • Sentiment Indicator: Neutral. The grant aligns executive and shareholder interests but the high potential dilution is a countervailing factor.

Investment Insights

Positive Market Indicators

  • The grant aligns the executive's interests with long-term shareholder value, as the value of the units is tied to the company's stock performance.

Risk Factors

  • The potential dilution of 4.88% from a single grant is a major red flag for shareholders.
  • The CAO's post-transaction potential ownership of over 42% of shares outstanding represents a significant concentration of control, which is highly unusual.

Key Takeaways

  1. A grant of 14,401 Profits Interest Units was awarded to the Chief Accounting Officer as part of a compensation plan.
  2. The transaction has a $0 value but represents a potential 4.88% dilution based on the provided shares outstanding data, making it highly significant.
  3. The insider's total potential holdings now represent over 42% of shares outstanding, an extremely high and noteworthy concentration.

Additional Context

Special Circumstances

  • The grant consists of Profits Interest Units (PIUs), which convert to OP Units. Each OP Unit is redeemable for one share of OHI common stock.
  • The units are subject to a three-year cliff vesting schedule, vesting on December 31, 2028, contingent on continued employment.
Topics:#SECFiling#InsiderTrading#OHI#OmegaHealthcare#Form4#EquityGrant#HighSignificance#StockMarket#REIT#FinancialAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.